Ndt Pharmaceuticals Stock Market Value
| NDTP Stock | USD 1.06 0.02 1.85% |
| Symbol | NDT |
NDT Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NDT Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NDT Pharmaceuticals.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in NDT Pharmaceuticals on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding NDT Pharmaceuticals or generate 0.0% return on investment in NDT Pharmaceuticals over 90 days. NDT Pharmaceuticals is related to or competes with Innate Pharma, Molecular Partners, Scancell Holdings, Brii Biosciences, JW Therapeutics, Hofseth BioCare, and Ascend Wellness. NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disor... More
NDT Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NDT Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NDT Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 14.8 | |||
| Information Ratio | 0.0723 | |||
| Maximum Drawdown | 123.04 | |||
| Value At Risk | (23.73) | |||
| Potential Upside | 40.91 |
NDT Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NDT Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NDT Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use NDT Pharmaceuticals historical prices to predict the future NDT Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0668 | |||
| Jensen Alpha | 1.88 | |||
| Total Risk Alpha | (1.02) | |||
| Sortino Ratio | 0.0991 | |||
| Treynor Ratio | (0.45) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NDT Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NDT Pharmaceuticals January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0668 | |||
| Market Risk Adjusted Performance | (0.44) | |||
| Mean Deviation | 12.85 | |||
| Semi Deviation | 12.97 | |||
| Downside Deviation | 14.8 | |||
| Coefficient Of Variation | 1292.17 | |||
| Standard Deviation | 20.29 | |||
| Variance | 411.49 | |||
| Information Ratio | 0.0723 | |||
| Jensen Alpha | 1.88 | |||
| Total Risk Alpha | (1.02) | |||
| Sortino Ratio | 0.0991 | |||
| Treynor Ratio | (0.45) | |||
| Maximum Drawdown | 123.04 | |||
| Value At Risk | (23.73) | |||
| Potential Upside | 40.91 | |||
| Downside Variance | 218.91 | |||
| Semi Variance | 168.13 | |||
| Expected Short fall | (17.80) | |||
| Skewness | 1.64 | |||
| Kurtosis | 5.37 |
NDT Pharmaceuticals Backtested Returns
NDT Pharmaceuticals is out of control given 3 months investment horizon. NDT Pharmaceuticals has Sharpe Ratio of 0.0794, which conveys that the firm had a 0.0794 % return per unit of standard deviation over the last 3 months. We were able to interpolate and analyze data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.62% are justified by taking the suggested risk. Use NDT Pharmaceuticals Mean Deviation of 12.85, risk adjusted performance of 0.0668, and Market Risk Adjusted Performance of (0.44) to evaluate company specific risk that cannot be diversified away. NDT Pharmaceuticals holds a performance score of 6 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -3.43, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning NDT Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, NDT Pharmaceuticals is expected to outperform it. Use NDT Pharmaceuticals potential upside, as well as the relationship between the kurtosis and period momentum indicator , to analyze future returns on NDT Pharmaceuticals.
Auto-correlation | -0.1 |
Very weak reverse predictability
NDT Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between NDT Pharmaceuticals time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NDT Pharmaceuticals price movement. The serial correlation of -0.1 indicates that less than 10.0% of current NDT Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Pair Trading with NDT Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NDT Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NDT Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to NDT Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NDT Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NDT Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NDT Pharmaceuticals to buy it.
The correlation of NDT Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NDT Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NDT Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NDT Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for NDT Pink Sheet Analysis
When running NDT Pharmaceuticals' price analysis, check to measure NDT Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NDT Pharmaceuticals is operating at the current time. Most of NDT Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NDT Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NDT Pharmaceuticals' price. Additionally, you may evaluate how the addition of NDT Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.